Determining Residue on Ignition in Pharmaceutical and Nutraceutical Products by Gravimetric Loss on Ignition Analysis
3 Dec 2014Pharmaceutical and Nutraceutical companies have a responsibility to ensure the drugs they are distributing are not only safe and effective for the consumers but are consistent between different batches and manufactures; this involves measuring the residue on ignition (ROI). The % ROI describes the amount of total concentration of inorganic salts and trace metals that fail to ignite at 600 °C. In this application note, Arizona Instrument was able to demonstrate equivalency between the traditional muffle furnace method and the Computrac® MAX® 5000XL Moisture and Ash Analyzer for several vitamins and supplements.
Links
Tags
RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. Drug TestingIt is essential to test the efficacy and toxicity of drugs at every stage of their development to ensure that a pharmaceutical product is fit for purpose and safe for use before reaching the stage of mass production and distribution.
